-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/update-methods-estimating-certainty-and-magnitude-net-benefit
April 01, 2019 - Update on Methods: Estimating Certainty and Magnitude of Net Benefit … stenosis screening. 1-2 Because carotid artery stenosis screening has both known benefits and harms, estimating … Update on the Methods: estimating certainty and magnitude of net benefit. … [PMID: 15684209]
Current as of: December 2007
Internet Citation: Update on Methods: Estimating
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/4y3P9DxovKMEjNmVd2mrPp
December 01, 2007 - Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit
Update on the Methods … Preventive Services Task Force:
Estimating Certainty and Magnitude of Net Benefit
George F. … Because
carotid artery stenosis screening has both known bene-
fits and harms, estimating net benefit
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/benefit.pdf
December 01, 2007 - Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit
Update on the Methods … Preventive Services Task Force:
Estimating Certainty and Magnitude of Net Benefit
George F. … Because
carotid artery stenosis screening has both known bene-
fits and harms, estimating net benefit
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-10-references
July 10, 2017 - Preventive Services Task Force: estimating certainty and magnitude of net benefit.
-
www.uspreventiveservicestaskforce.org/uspstf/document/update-on-the-methods-of-the-us-preventive-services-task-force-estimating-certainty-and-magnitude-of-net-bene%EF%AC%81t/carotid-artery-stenosis-screening-december-2007
December 15, 2007 - Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit
Carotid Artery Stenosis … Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit (PDF) … stenosis screening. 1-2 Because carotid artery stenosis screening has both known benefits and harms, estimating … Update on the Methods: estimating certainty and magnitude of net benefit.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-false-positive-and-false-negative-rates-of-/breast-cancer-screening-january-2016
January 11, 2016 - at the same radiology facility, we estimated robust SEs from logistic regression using generalized estimating … * 2-sided P values and 95% CIs were derived from a logistic regression model that used generalized estimating … 2-sided P values and 95% CIs were derived from a logistic regression model that used generalized estimating … 2-sided P values and 95% CIs were derived from a logistic regression model that used generalized estimating … 2-sided P values and 95% CIs were derived from a logistic regression model that used generalized estimating
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes
June 01, 2019 - 03/2009 Update on Methods: Insufficient Evidence ( PDF File , 229 KB) 12/18/2007 Update on Methods: Estimating
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KT7vaWK_JSDNNvEmUAjN8d
May 01, 2018 - Models of overdiagnosis
must attend carefully to the use of the appropriate data for estimating life … Estimating time of onset and clinical diagnosis requires
context-specific information on incidence and … MISCAN: estimating lead-time and over-detection by
simulation. BJU Int. 2003;92 Suppl 2:106-11. … Screening for prostate cancer: estimating the
magnitude of overdetection. … Estimating lead time and overdiagnosis associated with
PSA screening from prostate cancer incidence
-
www.uspreventiveservicestaskforce.org/uspstf/document/letter-to-the-editor-and-response-from-the-evidence-based-practice-center--human-papillomavirus-testing-to-screen-for-cervical-cancer/cervical-cancer-screening-2012
February 15, 2012 - Estimating both effectiveness and overdiagnosis requires longitudinal data from at least two screening … calculated that 3.2 additional CIN2/CIN3 would be treated to prevent 1 case of incident cancer as a means of estimating
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16812/prostate-models-overdiagnosis/pdf
May 01, 2018 - Models of overdiagnosis
must attend carefully to the use of the appropriate data for estimating life … Estimating time of onset and clinical diagnosis requires
context-specific information on incidence and … MISCAN: estimating lead-time and over-detection by
simulation. BJU Int. 2003;92 Suppl 2:106-11. … Screening for prostate cancer: estimating the
magnitude of overdetection. … Estimating lead time and overdiagnosis associated with
PSA screening from prostate cancer incidence
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTHBrY6VuqjoouJvUmtkr4
May 01, 2018 - Re-
estimating involved identifying values for each natural history component that allowed models to … Estimating lead time and overdiagnosis associated with
PSA screening from prostate cancer incidence … MISCAN: estimating lead-time and over-detection by
simulation. BJU Int. 2003;92 Suppl 2:106-11. … Screening for prostate cancer: estimating the
magnitude of overdetection. … Estimating the individual benefit of
immediate treatment or active surveillance for prostate cancer
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16813/prostate-cancer-models-overview/pdf
May 01, 2018 - Re-
estimating involved identifying values for each natural history component that allowed models to … Estimating lead time and overdiagnosis associated with
PSA screening from prostate cancer incidence … MISCAN: estimating lead-time and over-detection by
simulation. BJU Int. 2003;92 Suppl 2:106-11. … Screening for prostate cancer: estimating the
magnitude of overdetection. … Estimating the individual benefit of
immediate treatment or active surveillance for prostate cancer
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/weight-management-children-adolescents-interventions
February 10, 2022 - of pharmacotherapy): Large nonrandomized studies of interventions, defined as quantitative studies estimating
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/high-body-mass-index-children-adolescents-interventions
February 10, 2022 - of pharmacotherapy): Large nonrandomized studies of interventions, defined as quantitative studies estimating
-
www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-section-6-methods-arriving-recommendation
July 06, 2017 - Estimating the magnitude of benefit and harm of the preventive service. … Estimating the magnitude of the net benefit of the preventive service. … situations, the Task Force may also logically judge the lower bounds of the benefit, particularly when estimating
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-6-methods-arriving-recommendation
July 06, 2017 - Estimating the magnitude of benefit and harm of the preventive service. … Estimating the magnitude of the net benefit of the preventive service. … situations, the Task Force may also logically judge the lower bounds of the benefit, particularly when estimating
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study18/colorectal-cancer-screening
May 18, 2021 -
This analysis updated a 2016 modeling analysis estimating
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cTa7Hs56-yj4kCr7yXLdRm
July 01, 1994 - The lifetime probability of developing ovarian can-
cer is 1 in 70.
3.3 In estimating potential benefits … in women with
at least one ovary (compared with an unadjusted inci-
dence of 40 per 100 000).
3.4 Estimating … the test's perfor-
mance in screening asymptomatic women for ovarian can-
cer, is the ideal basis for estimating
-
www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/lung-cancer-screening
March 09, 2021 - Objective: To inform the USPSTF guidelines by estimating the benefits and harms associated with various
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6dqHx6xQGq9GUv92rZUf2q
August 01, 2022 - Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
The USPSTF recognizes that clinical decisions involve more considerations
than evidence alone. Clinicians should understand the evidence but
individualize decision making to the specific patient or situation.
Clinician Summary of USP…